MANDATO, Claudia
 Distribuzione geografica
Continente #
NA - Nord America 6.082
AS - Asia 5.440
EU - Europa 2.242
SA - Sud America 575
Continente sconosciuto - Info sul continente non disponibili 221
AF - Africa 87
OC - Oceania 1
Totale 14.648
Nazione #
US - Stati Uniti d'America 5.862
HK - Hong Kong 2.934
SG - Singapore 1.188
IT - Italia 1.139
CN - Cina 482
BR - Brasile 440
VN - Vietnam 363
RU - Federazione Russa 258
UA - Ucraina 165
FR - Francia 129
DE - Germania 121
IE - Irlanda 113
CA - Canada 95
IN - India 73
GB - Regno Unito 63
KR - Corea 63
BD - Bangladesh 58
TR - Turchia 58
FI - Finlandia 48
AR - Argentina 47
IL - Israele 47
SE - Svezia 47
MX - Messico 45
NL - Olanda 39
JP - Giappone 30
AT - Austria 29
IQ - Iraq 27
PL - Polonia 25
EC - Ecuador 24
ID - Indonesia 21
ZA - Sudafrica 20
ES - Italia 18
CO - Colombia 17
CR - Costa Rica 17
PK - Pakistan 17
TN - Tunisia 16
VE - Venezuela 16
SA - Arabia Saudita 12
HN - Honduras 11
JM - Giamaica 11
CZ - Repubblica Ceca 10
PH - Filippine 10
ET - Etiopia 9
MA - Marocco 9
PY - Paraguay 9
UZ - Uzbekistan 9
PE - Perù 8
SV - El Salvador 8
CL - Cile 7
DZ - Algeria 7
KE - Kenya 7
TT - Trinidad e Tobago 7
BY - Bielorussia 6
OM - Oman 6
AE - Emirati Arabi Uniti 5
EG - Egitto 5
EU - Europa 5
JO - Giordania 5
LB - Libano 5
LC - Santa Lucia 5
BB - Barbados 4
BE - Belgio 4
BO - Bolivia 4
DO - Repubblica Dominicana 4
MY - Malesia 4
NP - Nepal 4
RO - Romania 4
AZ - Azerbaigian 3
CW - ???statistics.table.value.countryCode.CW??? 3
GR - Grecia 3
GT - Guatemala 3
KW - Kuwait 3
LT - Lituania 3
NI - Nicaragua 3
SC - Seychelles 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
GD - Grenada 2
MD - Moldavia 2
MU - Mauritius 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SN - Senegal 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
AU - Australia 1
BH - Bahrain 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DM - Dominica 1
GE - Georgia 1
GF - Guiana Francese 1
GP - Guadalupe 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
Totale 14.417
Città #
Hong Kong 2.919
San Jose 816
Singapore 631
Ann Arbor 567
Ashburn 522
Milan 441
Dallas 345
Woodbridge 317
Chandler 288
Council Bluffs 284
Princeton 223
Jacksonville 195
Wilmington 167
Houston 157
Rome 141
Beijing 131
Lauterbourg 114
Naples 109
Dublin 104
The Dalles 101
Ho Chi Minh City 97
Santa Clara 82
Dong Ket 76
Los Angeles 70
Hanoi 66
New York 59
Moscow 51
Phoenix 45
São Paulo 45
Nanjing 41
Izmir 40
Dearborn 39
Boardman 36
Andover 35
Washington 35
Atlanta 33
Pellezzano 33
Chicago 31
Salerno 31
Brooklyn 29
Tokyo 28
Denver 26
Figino 26
Amsterdam 24
Orem 24
Mestre 23
San Francisco 22
Warsaw 22
Frankfurt am Main 21
Turin 21
Montreal 20
Vienna 20
London 19
Munich 19
Stockholm 19
Nuremberg 18
Seattle 18
Düsseldorf 16
Norwalk 16
Shenyang 16
Chennai 15
Fairfield 14
Baghdad 13
Bologna 13
Mexico City 13
Pune 13
San José 13
Columbus 12
Da Nang 12
Haiphong 12
Johannesburg 12
Quito 12
Memphis 11
Philadelphia 11
Rio de Janeiro 11
Seoul 11
Toronto 11
West Jordan 11
Brno 10
Caracas 10
Florence 10
Hebei 10
Jiaxing 10
San Diego 10
Tianjin 10
Ankara 9
Buenos Aires 9
Curitiba 9
Helsinki 9
Biên Hòa 8
Boston 8
Charlotte 8
Guayaquil 8
Nanchang 8
Poplar 8
San Pedro Sula 8
Shanghai 8
Tashkent 8
Vancouver 8
Addis Ababa 7
Totale 10.377
Nome #
Hepatitis B virus and the paediatric liver: waiting for news on the horizon 749
Pediatric liver diseases and ocular changes: What hepatologists and ophthalmologists should know and share with each other 374
Liver and Pancreatic Involvement in Children with Multisystem Inflammatory Syndrome Related to SARS-CoV-2: A Monocentric Study 372
Multiple gut-liver axis abnormalities in children with obesity with and without hepatic involvement 347
Pediatric parenteral nutrition-associated liver disease and cholestasis: Novel advances in pathomechanisms-based prevention and treatment. 328
Thyroid dysfunction and its role as a risk factor for non-alcoholic fatty liver disease: What's new 265
A systematic review of pediatrics NAFLD therapy: year 2012 257
Metabolomic salivary signature of pediatric obesity related liver disease and metabolic syndrome 247
Refractory primary sclerosing cholangitis becoming responsive after sulphasalazine treatment of an underlying silent colitis 218
A NEW POSSIBLE THERAPEUTIC STRATEGY IN OBESITYRELATED LIVER DISEASE: PRELIMINARY DATA WITH LACTOBACILLUS RHAMNOSUS STRAIN GG 206
Antioxidant vitamin E for the treatment of obesità related liver dysfunction in children with poor compliance to hypocaloric diets 205
Humanization interventions in general pediatric wards: a systematic review 200
Management of adults with paediatric-onset chronic liver disease: Strategic issues for transition care 195
Hepatic Presentation of Late-Onset Multiple Acyl-CoA Dehydrogenase Deficiency (MADD): Case Report and Systematic Review 193
Atypical celiac disease presenting as obesity-related liver dysfunction. 181
Novel congenital disorders of glycosylation may underlie cryptogenic liver disease in children. 178
Association of Very Rare NOTCH2 Variants with Clinical Features of Alagille Syndrome 176
Interplay between metabolic, oxidative, inflammatory and hormonal factors in pediatric obesity related liver disease. 168
Textbook of liver transplatation. Transition to Adult Care: Adolescents Care 164
Autoimmune manifestations in pediatric liver transplantation recipients 162
Oral vitamin E has beneficial effects on liver disease of obese children unable to loose weight 161
Autoantibodies against CYP-2C19: A Novel Serum Marker in Pediatric De Novo Autoimmune Hepatitis? 161
Chronic liver disease in two children exposed to moderately high levels of copper in drinking water. 159
Probiotics in the treatment of Non Alcoholic Fatty Liver Disease: Further evidence in obese children 153
LACTOBACILLUS RHAMNOSUS STRAIN GG DESERVES CONSIDERATION AS A THERAPEUTIC TOOL IN OBESITY-RELATED LIVER DISEASE 151
Frequent persistence of hepatic abnormalities in children with hereditary fructose intolerance (HFI) is not correlated to specific gene mutations. 150
Analgesic effects of breast- and formula feeding during routine childhood immunizations up to 1 year of age 149
Metabolic, hormonal, oxidative, and inflammatory factors in pediatricobesity-related liver disease 147
Autoimmune manifestations in children transplanted for non-autoimmune liver diseases 146
Cytochrome 2C19: a New Hepatic Target of Immune Reactions After Orthopic Liver Transplantation. 144
Probiotics: a possible role in treatment of adult and pediatric non alcoholic fatty liver disease 138
Gut-liver axis and probiotics: Their role in non-alcoholic fatty liver disease 136
A ZFYVE19 gene mutation associated with neonatal cholestasis and cilia dysfunction: case report with a novel pathogenic variant 133
Cryptogenic liver disease in four children: a novel congenital disorder of glycosylation 131
Insulin sensitivity and iron metabolism in pediatric obesity related liver disease. 131
Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions 131
More on current evidences on probiotics as a novel treatment for non-alcoholic Fatty liver disease 131
Congenital defects of glycosylation may underlie cryptogenic hepatopathy in asymptomatic children 128
Pediatric vs. adult NAFLD to MAFLD transition: a welcome but tangled path 126
Per-rectal portal scintigraphy is complementary to ultrasonography and endoscopy in the assessment of portal hypertension in children with chronic cholestasis 125
Chronic ingestion of moderately high copper may cause cryptogenic mild liver disease 124
Non-cirrhotic chronic liver disease in three italian children exposed to moderately high copper intakes 116
Human Parvovirus B19 Infection in liver transplanted children with chronic hematologic disorders. 116
Rhabdomyolysis and coeliac disease: A causal or casual association? A case report and review of literature 116
Humanization of pediatric care in the world: focus and review of existing models and measurement tools. 114
Vitamin E treatment in pediatric obesity-related liver disease: a randomized study. 113
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) antigen detection in the Emergency Department: data from a pediatric cohort during the fourth COVID-19 wave in Italy 113
Oxidative Stress in Non-alcoholic Fatty Liver Disease. An Updated Mini Review 110
Outbreak of paediatric myocarditis associated with parvovirus B19 infection in Italy, January to October 2024 108
Global multi-stakeholder endorsement of the MAFLD definition 104
More on vitamin E therapy 103
Diagnostic Approach to Acute Liver Failure in Children: A Position Paper by the SIGENP Liver Disease Working Group 98
Three unreported cases of TMEM199-CDG, a rare genetic liver disease with abnormal glycosylation 96
Case report: Reversible Fanconi syndrome due to vitamin D deficiency in a patient with epilepsy harbouring a pathogenic variant in the SLC34A1 gene 93
Laryngeal Mask for Minimally-Invasive Surfactant Administration: A Narrative Review 92
Multiple Sclerosis-Related Dietary and Nutritional Issues: An Updated Scoping Review with a Focus on Pediatrics 91
Case report: Unusual and extremely severe lipoprotein X-mediated hypercholesterolemia in extrahepatic pediatric cholestasis 91
Drug dosing in children with obesity: a narrative updated review 91
Pediatric Fatty Liver and Obesity: Not Always Justa Matter of Non-Alcoholic Fatty Liver Disease 91
Bassa statura non sindromica e ritardo puberale: non solo ritardo costituzionale di crescita e pubertà 87
Genotypes and different clinical variants between children and adults in progressive familial intrahepatic cholestasis: a state-of-the-art review 87
Ittero e feci ipocoliche: allarme atresia delle vie biliari 87
Liver Involvement in Congenital Disorders of Glycosylation: A Systematic Review 87
Clinical heterogeneity of Kabuki syndrome in a cohort of Italian patients and review of the literature 87
Crohn-Like Colitis in a Young Boy with Hirschsprung Disease 86
Real-word experience with Odevixibat in children with Progressive Familial Intrahepatic Cholestasis 84
Nutrition and Liver Disease 83
Diagnostic approach to neonatal and infantile cholestasis: A position paper by the SIGENP liver disease working group 83
Multisystem inflammatory syndrome in children. An emerging clinical challenge for pediatric surgeons in the COVID 19 era 81
Primary and Secondary Prophylaxis of Gastrointestinal Bleeding in Children with Portal Hypertension: A Multicenter National Study by SIGENP 81
ALAGILLE SYNDROME: IS IT ALWAYS CHOLESTASIS? 79
Malnutrition in pediatric chronic cholestatic disease: An up-to-date overview 79
Monkeypox Infection 2022: An Updated Narrative Review Focusing on the Neonatal and Pediatric Population 76
Cholestatic jaundice in infancy: Struggling with many old and new phenotypes 75
A persistent fever associated with elevated inflammatory indices and ultrasound lesions of liver and spleen 75
An odd septic arthritis of the hip 75
Celiac Disease on the Bed-Side: Embedding Case Finding and Screening in Hospitalized Children 74
Frailty in children with chronic liver disease: Growing evidence for an underexplored topic 73
Genetics, epigenetics and transgenerational transmission of obesity in children 73
The gut-liver axis as a target of liver disease management 73
Case Report: Add-on treatment with odevixibat in a new subtype of progressive familial intrahepatic cholestasis broadens the therapeutic horizon of genetic cholestasis 72
Consumptive Hypothyroidism due to Hepatic Hemangiomas: A Case Series and Review of the Literature 72
Emerging, re‐emerging and/or atypically behaving infectious diseases 71
Vitamin D Levels in the Pre- and Post-COVID-19 Pandemic Periods and Related Confinement at Pediatric Age 68
An almost accidentally diagnosis 67
Reasons why treatment of metabolic dysfunction‐associated steatotic liver disease may benefit from targeting the gut–liver axis as well 67
Odevixibat treatment reverses severe phenotype of PFIC in a young adult: A real-life experience beyond the genetic diagnosis 66
Systemic Cat-Scratch Disease: a "Troublesome" Diagnosis 65
Diagnosis and management of sclerosing cholangitis and inflammatory bowel disease in children: A survey by SIGENP 64
Pulmonary lipid modulation: A possible therapeutic target for SARS-CoV-2 infection 64
Acute hepatitis of unknown origin in children: Should we move the discussion from a purely infectious origin also to other plausible causes? 63
Pregnancy and Metabolic-Associated Fatty Liver Disease 61
Evaluation of non organ specific autoantibodies in children transplanted for non-autoimmune liver diseases 60
Letter to the editor in response to distinguishing autoimmune hepatitis from steatohepatitis in adolescents with obesity and positive screening alanine aminotransferase 60
The C677T mutation of the 5,1O-methylenetetrahydrofolate reductase gene is a moderate risk factor for spina bifida in Italy 60
Correction: Hammad, a.; kaido, t.; aliyev v.; mandato c.; uemoto s. nutritional therapy in liver transplantation (Nutrients, (2017) 9, E1126) 59
Perceptions and Expectations of Youth Regarding the Respect for Their Rights in the Hospital 58
Juvenile erythrocytosis in children after liver transplantation: prevalence, risk factors and outcome 58
Syphilitic hepatitis in infants, the forgotten disease that hepatologists have to brush up on: from a case series to a revision of literature 57
The complexity of diagnosing a drug reaction syndrome in the child|La complessità della diagnosi di una sindrome da reazione a farmaco nel bambino 57
Totale 12.950
Categoria #
all - tutte 48.629
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.629


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022352 0 0 0 0 6 2 1 10 52 39 51 191
2022/2023721 70 51 54 83 78 158 1 56 120 4 35 11
2023/2024533 29 48 43 25 32 89 41 24 14 43 24 121
2024/20251.193 21 22 19 54 42 190 185 100 184 101 175 100
2025/20268.042 375 1.840 1.514 322 658 282 987 241 329 570 158 766
2026/20271.635 174 185 530 743 3 0 0 0 0 0 0 0
Totale 14.648